|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
Infertility is a disease of the reproductive system. It is defined for most couples as not being able to get pregnant or maintain a pregnancy despite having frequent, unprotected, appropriately timed intercourse for at least a year. It is estimated that during their primary reproductive years, that 10 to 15 percent of couples in the United States are infertile. This condition affects both women and men. It is believed that almost 7 million women and 4 million men are affected by infertility.
Module 1 reviews the physiology of reproduction and the effects of hormone regulation on reproduction. The risk factors for infertility as well as the diagnostic tests used in identifying infertility will be discussed. The types of assisted reproductive technology available will also be reviewed.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
- Review the physiology of the reproductive endocrine system and how various hormones are regulated
- Identify risk factors for infertility in both women and men
- Explain appropriate diagnostic tests for the evaluation of an infertile patient
- Discuss types of fertility treatment options
Ann Scalia, BSN, RN, CNOR
Manager- Clinical Education Specialists
AllianceRx Walgreens Prime
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Ann Scalia is an employee of AllianceRx Walgreens Prime.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 04-05-2019
Expiration Date: 04-05-2022
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-129-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.